Central Valley Advisors LLC Takes Position in Colgate-Palmolive (NYSE:CL)

Central Valley Advisors LLC purchased a new position in shares of Colgate-Palmolive (NYSE:CL) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 3,030 shares of the company’s stock, valued at approximately $242,000.

Other large investors also recently modified their holdings of the company. M&G Investment Management Ltd. increased its position in shares of Colgate-Palmolive by 0.3% during the 4th quarter. M&G Investment Management Ltd. now owns 49,269 shares of the company’s stock worth $3,942,000 after purchasing an additional 125 shares during the last quarter. Wealthcare Advisory Partners LLC grew its position in shares of Colgate-Palmolive by 3.9% in the 4th quarter. Wealthcare Advisory Partners LLC now owns 3,404 shares of the company’s stock valued at $271,000 after acquiring an additional 127 shares during the period. &PARTNERS increased its stake in shares of Colgate-Palmolive by 0.7% during the 4th quarter. &PARTNERS now owns 17,643 shares of the company’s stock worth $1,406,000 after purchasing an additional 129 shares during the last quarter. AMG National Trust Bank raised its holdings in shares of Colgate-Palmolive by 0.4% in the 4th quarter. AMG National Trust Bank now owns 30,232 shares of the company’s stock valued at $2,410,000 after purchasing an additional 131 shares during the period. Finally, West Branch Capital LLC lifted its stake in Colgate-Palmolive by 24.0% in the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after purchasing an additional 132 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Colgate-Palmolive

In other news, insider Sally Massey sold 12,226 shares of the company’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the sale, the insider now directly owns 13,924 shares in the company, valued at approximately $1,309,691.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the transaction, the insider now owns 13,924 shares in the company, valued at $1,309,691.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider John W. Kooyman sold 3,497 shares of Colgate-Palmolive stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total transaction of $326,864.59. Following the transaction, the insider now directly owns 3,181 shares of the company’s stock, valued at $297,328.07. The disclosure for this sale can be found here. 0.37% of the stock is currently owned by company insiders.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock traded down $0.32 during trading hours on Wednesday, reaching $94.85. 1,618,121 shares of the stock traded hands, compared to its average volume of 4,576,535. Colgate-Palmolive has a one year low of $67.62 and a one year high of $95.59. The firm has a market capitalization of $77.82 billion, a price-to-earnings ratio of 29.98, a P/E/G ratio of 3.48 and a beta of 0.40. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 13.21. The company has a 50 day moving average price of $90.06 and a 200 day moving average price of $84.10.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, April 26th. The company reported $0.86 EPS for the quarter, topping the consensus estimate of $0.82 by $0.04. The firm had revenue of $5.07 billion for the quarter, compared to the consensus estimate of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The business’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter last year, the company earned $0.73 earnings per share. On average, equities research analysts expect that Colgate-Palmolive will post 3.53 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.11%. The ex-dividend date was Friday, April 19th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio is 63.29%.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on CL. Raymond James raised shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price objective on the stock in a research report on Monday, January 29th. UBS Group lifted their price target on Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, January 29th. Morgan Stanley increased their price objective on Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a research report on Monday, January 29th. Stifel Nicolaus upped their price target on shares of Colgate-Palmolive from $94.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, April 29th. Finally, Wells Fargo & Company boosted their price target on Colgate-Palmolive from $90.00 to $92.00 and gave the stock an “equal weight” rating in a report on Monday, April 29th. Three analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average price target of $92.35.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.